Glenmark recalls 6,528 bottles of blood pressure drug in US
Leading generic drug makers Lupin, Glenmark, and Natco Pharma are recalling products in the American market for manufacturing issues, according to the US health regulator.
Enforcement Report - Week of April 10, 2024
Glenmark Pharma on Tuesday moved the Delhi High Court, seeking setting aside the National Pharmaceutical Pricing Authority’s standing order that fixed a lower retail price than the launched price of its anti-diabetic drug formulations comprising Remogliflozin + Vidagliptin + Metmformin.
The Nashik Division of the Maharashtra Food and Drug Administration (FDA) has launched an inquiry into stickering and mislabelling practices observed on Glenmark's hypertension medication, Telma 40 and Telma 20 tab batches, produced in Sikkim.
Glenmark Pharma posts Q3 FY24 net loss of Rs. 331 Cr
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs
Glenmark partners with Pfizer to launch abrocitinib in India
Enforcement Report - Week of January 31, 2024
Ichnos and Glenmark take a collaborative leap